Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Heritage Bio Labs

Research Library

Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.

Browse by productGeneral topics

Find articles

All articles

Showing 337–348 of 411 articles

  • Check methods and identity

    How to Read a Semax Brain Imaging Result in Healthy Volunteers

    Semax is a synthetic seven-amino-acid peptide. An older imaging study compared Semax, Selank and placebo in healthy volunteers. This direct study measured brain connectivity over a short interval rather than showing whether cognition or daily function improved.

    Semax1 source (2020)

  • Explore study findings

    What the Interim Compounding Policy Actually Covers for Semax

    Semax is a synthetic seven-amino-acid peptide. In 2026, FDA and HHS documents discussed specific Semax-related bulk substances. These sources explain a regulatory context, not a finding that Semax improves memory or recovery.

    Semax3 sources (2026)

  • Check methods and identity

    Why a urine test measures both sermorelin and a breakdown product

    Sermorelin is the synthetic, amidated version of the first 29 residues of human growth hormone–releasing hormone (GHRH). An analytical study asked how to distinguish this peptide and a breakdown product from related substances in urine.

    Sermorelin2 sources (2013, 2025)

  • Explore study findings

    What the FDA's Geref records say about its former indications

    Sermorelin is a synthetic 29-residue fragment of human growth hormone–releasing hormone, with an amidated end. The history of Geref, a U.S. sermorelin acetate product, shows how a diagnostic approval and a treatment approval can address separate questions.

    Sermorelin2 sources (1996, 2013)

  • Check methods and identity

    How an older HIV study measured changes in body composition

    Sermorelin is a synthetic version of the first 29 amino acids of growth hormone–releasing hormone (GHRH). A human trial asked whether the older Geref product changed hormone and body composition measurements in men with HIV-associated lipodystrophy.

    Sermorelin2 sources (2004, 2013)

  • Understand the science

    Why a releasing signal produced different growth hormone responses after radiation

    Sermorelin is the amidated first 29 residues of growth hormone–releasing hormone (GHRH), prepared as a synthetic peptide.

    Sermorelin2 sources (1999, 2013)

  • Check methods and identity

    What a year of height measurements showed in a pediatric study

    Sermorelin is a synthetic 29-residue fragment of human growth hormone–releasing hormone. In an older multicenter study, researchers asked whether children with growth hormone deficiency grew faster over the first year while receiving the fragment.

    Sermorelin2 sources (1996, 2013)

  • Interpret the evidence

    How researchers separated peptide absorption from a hormone response

    Sermorelin is an amidated 29-amino-acid fragment of human growth hormone–releasing hormone (GHRH). An early study in volunteers compared how much of this fragment reached blood and how long the downstream hormone response lasted under different experimental conditions.

    Sermorelin2 sources (1993, 2013)

  • Explore study findings

    What human liver fractions revealed about SLU-PP-332 breakdown

    SLU-PP-332 is a small synthetic compound with a different chemical structure from a peptide. It activates a group of proteins called estrogen-related receptors. In 2026, two laboratories examined what happened to the compound when exposed to enzymes prepared from human liver tissue.

    SLU-PP-3323 sources (2023, 2026)

  • Understand the science

    How chemists used SLU-PP-332 to design related compounds

    SLU-PP-332 is a small nonpeptide molecule that activates estrogen-related receptors, or ERRs. A 2026 study used its chemical structure as a starting point and asked which changes affected receptor signaling and properties such as solubility.

    SLU-PP-3321 source (2026)

  • Explore study findings

    Why SLU-PP-915 results belong to a different compound

    SLU-PP-332 is a synthetic small molecule outside that class. It acts on estrogen-related receptors, which help regulate genes involved in energy metabolism. A recent animal study compared it with another small molecule called SLU-PP-915 and examined which effects were shared.

    SLU-PP-3321 source (2025)

  • Check methods and identity

    What an older mouse study measured about fat as fuel

    SLU-PP-332 is a synthetic nonpeptide activator of estrogen-related receptors. An older study tested what happened to energy use and body composition in two mouse models of obesity and metabolic dysfunction. One model used diet to induce obesity.

    SLU-PP-3321 source (2024)

Browse by product

General topics

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Library index (JSON)